Effects of fasudil on early atherosclerotic plaque formation and established lesion progression in apolipoprotein E-knockout mice

被引:52
|
作者
Wu, Duo-Jiao [1 ]
Xu, Jian-Zhong [1 ]
Wu, Yong-Jie [1 ]
Jean-Charles, Lafarge [2 ]
Xiao, Bing [1 ]
Gao, Ping-Jin [1 ,3 ]
Zhu, Ding-Liang [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Key Lab Vasc Biol, Shanghai Inst Hypertens,Dept Cellular & Mol Biol, Key Lab Med Genom,Ruijin Hosp,Sch Med, Shanghai 200025, Peoples R China
[2] Sino French Res Ctr Life Sci & Genom, Shanghai, Peoples R China
[3] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci Ctr, Lab Vasc Biol, Shanghai, Peoples R China
关键词
Fasudil; Atherosclerosis; Plaque; Micro-ultrasound; Mice; RHO-KINASE; ULTRASOUND; PRAVASTATIN; INHIBITOR; SYSTEM; ARTERY; WALL;
D O I
10.1016/j.atherosclerosis.2009.04.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rho kinases have been shown to be involved in the pathogenesis of atherosclerosis. This study examined the effects of fasudil, a specific Rho kinase inhibitor, on plaque development and progression in atherosclerotic mice. Sixty apolipoprotein E-knockout (apoE-KO) mice were fed a high-fat diet. Mice started to receive fasudil at the same time as fat feeding (early treatment), or after 12 weeks of fat feeding (delayed treatment). In each administrative schedule, mice were divided into three groups: low dose fasudil group (30 mg/kg/day), high dose fasudil group (100 mg/kg/day) and control group (tap water) (n = 10, respectively). Plaque size was determined by using ultrasound biomicroscopy (UBM) and histological examinations. Brachiocephalic artery UBM analysis showed that in early treatment, both doses of fasudil significantly reduced lesion size compared with the controls (P < 0.05). In delayed-fasudil treatment, plaque area was reduced by 54% (P < 0.05) after 12 weeks of treatment at a high dose of fasudil (100 mg/kg/day). The UBM findings were confirmed by histological studies at the corresponding arterial sites. The beneficial effect was also observed in the left common carotid arteries that delayed-fasudil treatment reduced the plaque size in a dose-dependent manner. The arterial intima-medial thickness (IMT) and maximal flow velocity of both arteries were lower in fasudil-treated group (100 mg/kg/day) in comparison with the control mice. Furthermore, fasudil treatment (100 mg/kg/day) reduced the macrophage accumulation in atherosclerotic lesions. However, fasudil had no effects on blood pressure and plasma lipid concentrations in both studies. In conclusion, our studies showed that blocking Rho kinase reduced both the early development and later progression of atherosclerotic plaques in apoE-KO mice by using a novel micro-ultrasound approach. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:68 / 73
页数:6
相关论文
共 50 条
  • [1] EFFECTS OF FASUDIL ON EARLY ATHEROSCLEROTIC PLAQUE FORMATION AND ESTABLISHED LESION PROGRESSION IN APOLIPOPROTEIN E-KNOCKOUT MICE
    Wu, D.
    Gao, P.
    Zhu, D.
    JOURNAL OF HYPERTENSION, 2009, 27 : S321 - S322
  • [2] Exercise Inhibiting Atherosclerotic Lesion Formation in Apolipoprotein E-Knockout Mice by Regulating Oxidative Stress
    Yuan Ling-yan
    Cheng Hong
    Pan Guo-jian
    Lu Ai-yun
    PROCEEDINGS OF THE 21ST PAN-ASIAN CONGRESS OF SPORTS AND PHYSICAL EDUCATION, VOL 4: APPLICATION OF PHYSIOLOGY AND PSYCHOLOGY IN SPORTS, 2010, : 44 - 48
  • [3] Postnatal blocking of interferon-γ function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice
    Koga, Mitsuhisa
    Kai, Hisashi
    Yasukawa, Hideo
    Kato, Seiya
    Yamamoto, Tomoka
    Kawai, Yumiko
    Kusaba, Ken
    Seki, Yukihiko
    Kai, Mamiko
    Egashira, Kensuke
    Kataoka, Yasufumi
    Imaizumi, Tsutomu
    HYPERTENSION RESEARCH, 2007, 30 (03) : 259 - 267
  • [4] A novel oral neutrophil elastase inhibitor, ONO-6818, suppressed early atherosclerotic plaque formation in apolipoprotein E-knockout mice
    Iso, Y
    Suzuki, H
    Soda, T
    Tsunoda, F
    Sato, T
    Shoji, M
    Koba, S
    Geshi, E
    Katagoro, T
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 465A - 465A
  • [5] Insulin inhibits atherosclerotic plaque formation in apolipoprotein E knockout mice
    Breen, Danna M.
    Guo, June
    Franco, Christopher
    Mroziewicz, Margaret
    Bendeck, Michelle P.
    Giacca, Adria
    DIABETES, 2008, 57 : A72 - A72
  • [6] ERYTHROPOIETIN PREVENT PLAQUE DISRUPTION IN APOLIPOPROTEIN E-KNOCKOUT MICE
    Cui Jinjin
    He, Jieqiong
    Dong, Nana
    Cao, Wei
    Hou, Jingbo
    Yu, Bo
    HEART, 2013, 99 : E41 - E42
  • [7] The effect of clopidogrel on atherosclerotic plaque progression and rupture in apolipoprotein E knockout mice
    Williams, H
    Baker, N
    Poole, A
    Jackson, CL
    ATHEROSCLEROSIS, 2005, 181 (01) : S6 - S6
  • [8] The effects of interleukin-6 deficiency on atherosclerotic lesion progression in apolipoprotein E knockout mice
    Sukovich, DA
    Kauser, K
    Rubanyi, GM
    CIRCULATION, 1999, 100 (18) : 43 - 43
  • [9] Atorvastatin Upregulates the Expression of miR-126 in Apolipoprotein E-knockout Mice with Carotid Atherosclerotic Plaque
    Pan, Xudong
    Hou, Rongyao
    Ma, Aijun
    Wang, Ting
    Wu, Mei
    Zhu, Xiaoyan
    Yang, Shaonan
    Xiao, Xing
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2017, 37 (01) : 29 - 36
  • [10] Safrole-2′,3′-oxide induces atherosclerotic plaque vulnerability in apolipoprotein E-knockout mice
    Su, Le
    Zhang, HaiYan
    Zhao, Jing
    Zhang, ShangLi
    Zhang, Yun
    Zhao, BaoXiang
    Miao, JunYing
    TOXICOLOGY LETTERS, 2013, 217 (02) : 129 - 136